analiza aiqbench
This research introduces OPAL, a novel framework for certifying adaptive experimentation in laboratories by establishing strict preconditions where decision-time information justifies policy changes. By defining an impossibility boundary under unrestricted outcome shifts, the study provides essential safety guarantees and risk controls that are critical for deploying autonomous agents in high-stakes scientific environments like pharmacogenomics. The work advances AI Safety within Machine Learning by formalizing authorization as a distinct layer to prevent misalignment between adaptive policies and intended outcomes.
Certifying when decision-time information justifies adaptive experimentation
arXiv:2607.27651v1 Announce Type: new Abstract: Adaptive laboratories choose measurements during experiments, yet most methods begin after adaptation is permitted. We introduce Opportunity-aware Policy Authorization for Laboratories (\OPAL{}), a framework that decides whether adaptation should be enabled at all. \OPAL{} uses a precommitted contract to require non-trivial adaptation, controlled target risk and positive executed value after cost. We establish an impossibility boundary: source outcomes and unlabelled target covariates cannot uniformly support non-trivial authorization under unrestricted conditional outcome shift, and derive a target-calibrated recovery. Applied to an unseen 11,265-compound Cell Painting partition, the frozen gate selected 595 compounds, captured 384 positive opportunities and achieved strictly positive executed value under least-favourable completion; its 5.18\% false-activation upper bound remained below a 7.5\% limit. Among six methods, only \OPAL{} combined non-zero activation with this risk control. Locked pharmacogenomic and finite-campaign studies distinguish policy misalignment from non-certifiability, establishing authorization as a distinct layer for safe adaptive science.
Abstract:Adaptive laboratories choose measurements during experiments, yet most methods begin after adaptation is permitted. We introduce Opportunity-aware Policy Authorization for Laboratories (\OPAL{}), a framework that decides whether adaptation should be enabled at all. \OPAL{} uses a precommitted contract to require non-trivial adaptation, controlled target risk and positive executed value after cost. We establish an impossibility boundary: source outcomes and unlabelled target covariates cannot uniformly support non-trivial authorization under unrestricted conditional outcome shift, and derive a target-calibrated recovery. Applied to an unseen 11,265-compound Cell Painting partition, the frozen gate selected 595 compounds, captured 384 positive opportunities and achieved strictly positive executed value under least-favourable completion; its 5.18\% false-activation upper bound remained below a 7.5\% limit. Among six methods, only \OPAL{} combined non-zero activation with this risk control. Locked pharmacogenomic and finite-campaign studies distinguish policy misalignment from non-certifiability, establishing authorization as a distinct layer for safe adaptive science.
Machine Learning (cs.LG)
arXiv:2607.27651 [cs.LG]
(or arXiv:2607.27651v1 [cs.LG] for this version)
https://doi.org/10.48550/arXiv.2607.27651 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Text integral sub licența deschisă a publicației · 240 cuvinte
Subiecte conexe

Expenditure Horizon: Measuring Optimization Ability, with an Application to NanoGPT
METR · 21 iul. 2026
Certify the Decision, Not Every Score: Exact Top-k Selection from Few Evaluations
arXiv · 15 oct. 2026

Import AI 473: The US’s superintelligence strategy; human brain in a mouse skull; and machine hermeneutics
Import AI · 21 sept. 2026

[AINews] Reality Checks on AI News (Yegge shuts down Gas Town, Databricks’ +60% Astra cost)
Latent Space · 17 sept. 2026